Skip to content
healthcare.dev

OXLUMO

NDC 71336-1002, lumasiran, injection, solution, from Alnylam Pharmaceuticals, Inc..

Product NDC
71336-1002
Status
Listed
Labeler
Alnylam Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA214103
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LUMASIRAN SODIUM94.5 mg/.5mL
Package NDCNDC-11Package
71336-1002-1713361002011 VIAL, SINGLE-USE in 1 CARTON (71336-1002-1) / .5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/16985a31-f5e4-4557-9266-fc78d4bc5055
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71336-1002

Use it

Look up 71336-1002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71336-1002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71336-1002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.